ADVANCED COLORECTAL CANCER
Clinical trials for ADVANCED COLORECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED COLORECTAL CANCER trials appear
Sign up with your email to follow new studies for ADVANCED COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Drug attack targets Tough-to-Treat cancers
Disease control OngoingThis study is testing a new oral drug, JAB-21822, combined with an existing cancer drug called cetuximab. It is for people with advanced colorectal, small intestine, or appendix cancers that have a specific genetic change called KRAS G12C. The main goals are to find a safe and ef…
Matched conditions: ADVANCED COLORECTAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Allist Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Clear colonoscopy, hidden danger? study hunts best cancer check for High-Risk group
Disease control ENROLLING_BY_INVITATIONThis study aims to find the best way to monitor people who have a positive stool test for hidden blood but a colonoscopy that finds nothing. Researchers are comparing two follow-up plans: doing another stool test in two years versus doing another colonoscopy in two years. The goa…
Matched conditions: ADVANCED COLORECTAL CANCER
Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC